Younkin, Curtis S
Mayo Clinic
Department of Neuroscience, Mayo Clinic Florida, Jacksonville, FL, USA.
Citations 2
Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases
Allen, Mariet , Wang, Xue , Burgess, Jeremy D. , Serie, Daniel, Younkin, Curtis, Nguyen, Thuy , Malphrus, Kimberly G., Lincoln, Sarah, Carrasquillo, Minerva M. , Ho, Charlotte C.G. , Chakrabarty, Paramita , Strickland, Samantha L. , Murray, Melissa E. , Geschwind, Daniel H. , Seyfried, Nicholas T. , Dammer, Eric B. , Levey, Allan I. , Golde, Todd E. , Funk, Cory C. , Li, Hongdong , Price, Nathan D. , Petersen, Ronald C. , Graff‐Radford, Neill R. , Younkin, Steven G. , Crook, Julia, Asmann, Yan W. , Ertekin‐Taner, Nilüfer , Watzlawik, Jens, Serie, Daniel J, Younkin, Curtis S, Ho, Charlotte, Crook, Julia R, Price, Nathan D , Murray, Melissa E , Watzlawik, Jens O. , Carrasquillo, Minerva M. , Swarup, Vivek , Lah, James J. , Li, Hongdong, Dickson, Dennis W. , Dammer, Eric B , Levey, Allan I
Alzheimer's & Dementia | October 31, 2017 | Volume: 14 | Issue: 3 | Pages: 352-366
Abstract Introduction Comparative transcriptome analyses in Alzheimer's disease (AD) and other neurodegenerative proteinopathies can uncover both shared and distinct disease pathways. Methods We analyzed 940 brain transcriptomes including patients with AD, progressive supranuclear palsy (PSP; a primary tauopathy), and control subjects. Results We identified transcriptional coexpression networks implicated in myelination, which were lower in PSP temporal cortex (TCX) compared with AD. Some of these associations were retained even after adjustments for brain cell population changes. These TCX myelination network structures were preserved in cerebellum but they were not differentially expressed in cerebellum between AD and PSP. Myelination networks were downregulated in both AD and PSP, when compared with control TCX samples. Discussion Downregulation of myelination networks may underlie both PSP and AD pathophysiology, but may be more pronounced in PSP. These data also highlight conservation of transcriptional networks across brain regions and the influence of cell type changes on these networks.
A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression
Carrasquillo, Minerva M., Allen, Mariet , Burgess, Jeremy D. , Wang, Xue , Strickland, Samantha L. , Aryal, Shivani , Siuda, Joanna , Kachadoorian, Michaela, Medway, Christopher, Younkin, Curtis, Nair, Asha, Chanana, Pritha , Serie, Daniel, Nguyen, Thuy , Lincoln, Sarah, Malphrus, Kimberly G., Morgan, Kevin , Golde, Todd E. , Price, Nathan D. , White, Charles C. , Jager, Philip L. De , Bennett, David A. , Asmann, Yan W. , Petersen, Ronald , Graff‐Radford, Neill R., Younkin, Steven G., Ertekin‐Taner, Nilüfer , Kachadoorian, Michaela L, Younkin, Curtis S, Crook, Julia E. , Bennett, David A. , Carrasquillo, Minerva M. , Siuda, Joanna S. , Wang, Chen , Graff‐Radford, Neill R., Dickson, Dennis W. , Price, Nathan D
Alzheimer's & Dementia | December 8, 2016 | Volume: 13 | Issue: 6 | Pages: 663-673
AbstractIntroductionWe hypothesized that common Alzheimer's disease (AD)‐associated variants within the triggering receptor expressed on myeloid (TREM) gene cluster influence disease through gene expression.MethodsExpression microarrays on temporal cortex and cerebellum from ∼400 neuropathologically diagnosed subjects and two independent RNAseq replication cohorts were used for expression quantitative trait locus analysis.ResultsA variant within a DNase hypersensitive site 5′ of TREM2, rs9357347‐C, associates with reduced AD risk and increased TREML1 and TREM2 levels (uncorrected P = 6.3 × 10−3 and 4.6 × 10−2, respectively). Meta‐analysis on expression quantitative trait locus results from three independent data sets (n = 1006) confirmed these associations (uncorrected P = 3.4 × 10−2 and 3.5 × 10−3, Bonferroni‐corrected P = 6.7 × 10−2 and 7.1 × 10−3, respectively).DiscussionOur findings point to rs9357347 as a functional regulatory variant that contributes to a protective effect observed at the TREM locus in the International Genomics of Alzheimer's Project genome‐wide association study meta‐analysis and suggest concomitant increase in TREML1 and TREM2 brain levels as a potential mechanism for protection from AD.